%0 Journal Article
%T Smell loss is associated with cognitive impairment in amyotrophic lateral sclerosis patients.
%A Huang X
%A Wu J
%A Zhang N
%A Teng J
%A Yang Q
%A Zhang Y
%A Yin T
%A Zhou W
%A Fan D
%A Ye S
%J CNS Neurosci Ther
%V 30
%N 7
%D 2024 Jul
%M 38978196
%F 7.035
%R 10.1111/cns.14851
%X <B>BACKGROUND: </B>Smell loss significantly impacts the quality of life in patients. However, there is limited research on smell loss in individuals with amyotrophic lateral sclerosis (ALS), and the correlation between smell loss and cognitive impairment is unclear. This study aimed to investigate the correlation between smell loss and cognition impairment in ALS patients.<BR><B>METHODS: </B>The study included 216 ALS patients. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and smell identification test specifically for the Chinese population (CSIT) were administered to evaluate participants' cognitive and olfactory function, respectively.<BR><B>RESULTS: </B>After covarying for age, sex, BMI, education level, degree of hunger, dietary bias, eagerness for food, stress, smoking status, alcohol consumption, and upper respiratory tract infection (URTI) or rhinitis, CSIT scores were significantly correlated with ECAS scores (r = 0.162, p = 0.028), especially the ALS-specific scores (r = 0.158, p = 0.031). Even after excluding patients with URTI or rhinitis, the results were similar. CSIT scores were significantly correlated with ECAS scores (r = 0.224, p = 0.011), especially the ALS-specific scores (r = 0.205, p = 0.019).<BR><B>CONCLUSIONS: </B>In patients with ALS, smell loss is significantly correlated with cognitive impairment, particularly frontotemporal dysfunction. Cognitive dysfunction may lead to worse olfactory performance in ALS patients.